TEG can monitor the dynamic changes of blood clot formation and lysis by activating the coagulation system of a small sample of whole blood in vitro. The parameters can reflect the level of coagulation factors, the function of fibrinogen and platelet, and the presence or absence of hyperfibrinolysis. At present, the normal reference range of the parameters of TEG is mainly based on the reference values established by the Western population. Due to the differences in the distribution of ethnic groups, many countries have established their reference ranges for healthy populations. In China, some scholars have tried to establish the corresponding TEG reference range according to the characteristics of the population in different regions. This study tried to establish the reference range for thromboelastography in healthy middle-aged and elderly people of Weihai in China and compare it with the reference range provided by the manufacturer. The fasting venous blood of 454 healthy middle-aged and elderly people was collected, including 239 males and 215 females. The thromboelastography TEG-5000 was used to measure the reaction time (R), coagulation formation time (K), coagulation angle (Angle), and maximum amplitude (MA). The reference range of TEG parameters of middle-aged and elderly healthy males was R: 4.38-8.27 min, K: 1.44-2.82 min, Angle: 48.53-72.17 deg, and MA: 51.95-72.02 mm; respectively, in the females, the normal value was R: 3.43-7.40 min, K: 1.07-2.53 min, Angle: 48.22-77.22 deg, and MA: 53.10-74.58 mm; The difference of R, K, Angle, and MA between the male group and the female group was statistically significant ( < 0.05); In this study, if we use the reference range established by the manufacturer, the R specificity for males was 91.6%, K specificity was 98.7%, Angle specificity was 85.8%, and MA specificity was 93.7%; the range for females was 68.4%, 99.5%, 75.8%, and 87.4%, respectively. There are statistically significant differences between R, K, Angle, and MA in middle-aged and elderly healthy women and men. It is necessary to establish a TEG reference range for healthy females and males.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645399PMC
http://dx.doi.org/10.1155/2021/7119779DOI Listing

Publication Analysis

Top Keywords

reference range
20
middle-aged elderly
16
healthy middle-aged
12
elderly people
12
range thromboelastography
8
thromboelastography healthy
8
people weihai
8
weihai china
8
time coagulation
8
reference
7

Similar Publications

Blood-based epigenome-wide association study and prediction of alcohol consumption.

Clin Epigenetics

January 2025

Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.

Alcohol consumption is an important risk factor for multiple diseases. It is typically assessed via self-report, which is open to measurement error through recall bias. Instead, molecular data such as blood-based DNA methylation (DNAm) could be used to derive a more objective measure of alcohol consumption by incorporating information from cytosine-phosphate-guanine (CpG) sites known to be linked to the trait.

View Article and Find Full Text PDF

MUC1 and glycan probing of CA19-9 captured biomarkers from cyst fluids and serum provides enhanced recognition of ovarian cancer.

Sci Rep

January 2025

Department of Life Technologies, Division of Biotechnology, University of Turku, Medisiina D, 5th floor, Kiinamyllynkatu 10, 20520, Turku, Finland.

Glycosylation changes of circulating proteins carrying the CA19-9 antigen may offer new targets for detection methods to be explored for the diagnosis of epithelial ovarian cancer (EOC). Search for assay designs for targets initially captured by a CA19-9 antigen reactive antibody from human body fluids by probing with fluorescent nanoparticles coated with lectins or antibodies to known EOC associated proteins. CA19-9 antigens were immobilized from ascites fluids, ovarian cyst fluids or serum samples using monoclonal antibody C192 followed by probing of carrier proteins using anti-MUC16, anti-MUC1 and, anti STn antibodies and seven lectins, all separately coated on nanoparticles.

View Article and Find Full Text PDF

Assessment of deep learning technique for fully automated mandibular segmentation.

Am J Orthod Dentofacial Orthop

February 2025

Department of Orthodontics, Faculty of Dentistry, Çanakkale Onsekiz Mart University, Çanakkale, Turkey.

Introduction: This study aimed to assess the precision of an open-source, clinician-trained, and user-friendly convolutional neural network-based model for automatically segmenting the mandible.

Methods: A total of 55 cone-beam computed tomography scans that met the inclusion criteria were collected and divided into test and training groups. The MONAI (Medical Open Network for Artificial Intelligence) Label active learning tool extension was used to train the automatic model.

View Article and Find Full Text PDF

Determining the cosmetics usage patterns of consumers for exposure assessment in China.

Food Chem Toxicol

January 2025

School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou, Guangdong 510006, China. Electronic address:

Accurately understanding the usage patterns of cosmetics is crucial for realistic exposure assessment. However, reference values for consumer exposure to cosmetics in China have yet to be established. A continuous survey was conducted in Guangdong Province to address this deficiency.

View Article and Find Full Text PDF

Development and validation of a sensitive LC-MS/MS assay for determination of upadacitinib in human plasma and its application in patients with inflammatory bowel disease.

J Pharmacol Toxicol Methods

January 2025

Department of Pharmacy, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; Department of Gastroenterology, the Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. Electronic address:

Background: Upadacitinib is a selective Janus kinase (JAK) 1 inhibitor approved by the Food and Drug Administration for the treatment of moderate-to-severe inflammatory bowel disease (IBD). We aimed to establish and validate a method for determining Upadacitinib in patients with IBD by liquid chromatography-tandem mass spectrometry (LC-MS/MS) method.

Methods: The mobile phase was 0.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!